Corticosteroids plus standard of care treatment versus standard of care treatment alone to prevent heart complications in Kawasaki disease
Kawasaki disease is a rare condition that causes blood vessels across the body to become swollen and inflamed. It is particularly dangerous when it affects the arteries supplying blood to the heart. The usual treatment is aspirin alongside a drip of antibodies called IVIG. However, around one in five children in the UK still develop heart problems despite this treatment. This trial is looking to see if adding a steroid medicine called prednisolone to the usual care can better prevent heart damage. Children aged between 30 days and 15 years who have Kawasaki disease can take part. Half the patients will receive standard care, and half will receive standard care plus steroid medicine for two to three weeks. Doctors will track their heart health using painless ultrasound scans over 12 weeks to see which treatment works best.
Överblick
Vad handlar denna studie om?
Kawasaki disease is an illness that mainly affects young children. It causes blood vessels throughout the body to become inflamed and swollen. While the exact cause is still unknown, doctors know that early treatment is vital. Without quick treatment, the swelling can weaken the coronary arteries—the blood vessels that feed the heart—causing lasting damage or bulging known as aneurysms.
The current standard treatment involves an infusion of healthy donor antibodies (called IVIG) and aspirin to quickly reduce inflammation. Although this treatment helps most young patients, about 19% of children with Kawasaki disease in the UK still experience heart damage. Doctors are urgently searching for ways to improve this outcome and prevent long-term heart trouble.
This study, called KD-CAAP, tests whether giving a well-known anti-inflammatory medicine called prednisolone (a corticosteroid) alongside the usual IVIG and aspirin gives extra protection. Steroids have been used safely for decades to calm the immune system in other conditions. By comparing children who receive steroids with those who receive standard treatment alone, researchers hope to discover the safest, most effective way to protect children's hearts.
Viktiga punkter
- The trial looks at whether adding a steroid medicine to standard care prevents heart damage in Kawasaki disease.
- Open to children and young people aged 30 days to 15 years diagnosed with Kawasaki disease.
- All participants receive the standard care of IVIG antibodies and aspirin.
- Half of the participants also receive the steroid prednisolone for two to three weeks.
- Follow-up lasts 12 weeks and includes painless heart ultrasound scans.
- Participation is voluntary and standard medical care is guaranteed throughout.
Vem kan vara berättigad?
This trial is open to babies, children, and young people aged between 30 days and 15 years old who have been diagnosed with Kawasaki disease.
A doctor diagnoses Kawasaki disease based on specific symptoms. These include a high fever lasting five days or more, combined with signs such as a rash, bloodshot eyes, swollen neck glands, red cracked lips or a 'strawberry' tongue, and redness or peeling on the hands and feet. Children with 'incomplete' Kawasaki disease—meaning they have a fever and some, but not all, of these symptoms alongside unusual blood tests—may also be eligible.
Parents or legal guardians must give written permission for their child to join. Older children and teenagers will also be asked if they agree to take part.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- My child is aged between 30 days and 15 years old.
- My child has been diagnosed with Kawasaki disease (or suspected incomplete Kawasaki disease).
- My child has had a high fever alongside other symptoms like a rash, red eyes, swollen neck glands, or red lips and tongue.
- My child is ready to start treatment at a participating hospital.
- I am the parent or legal guardian and can provide written consent.
Vad innebär deltagande?
If your child joins the study, a computer will place them into one of two groups by chance (randomly). Both groups receive the full standard care of IVIG and aspirin. One group will also receive prednisolone, either as a liquid or tablet by mouth, or through a vein if needed, for two to three weeks. If your child still has a fever or swelling after starting treatment, doctors will give them extra medication regardless of their group.
Most children stay in hospital for the first 5 to 7 days of treatment, which is normal for Kawasaki disease. After leaving the hospital, there will be just three follow-up visits over a 12-week period. During these visits, doctors will check your child's recovery using blood tests and painless heart ultrasound scans (echocardiograms) to see how the heart arteries are healing.
Potentiella risker och fördelar
Platser (56)
- Great Ormond Street Hospital For Children NHS Foundation TrustEndast stadLondon, England
- Guy's och St Thomas' NHS Foundation TrustObekräftadLondon NO COUNTRY SPECIFIED, assuming England, England
- The Newcastle Upon Tyne Hospitals NHS Foundation TrustEndast stadNewcastle-upon-Tyne, England
- Belfast Health & Social Care TrustEndast stadBelfast, Northern Ireland
- NHS Större Glasgow och ClydeEndast stadGlasgow, Scotland
- Universitetssjukhuset Southampton NHS Foundation TrustEndast stadSouthampton, England
- St George's University Hospitals NHS Foundation TrustObekräftadLondon, England
- Imperial College Healthcare NHS TrustObekräftadLondon, England
- Barts Health NHS TrustObekräftadLondon, England
- Whittington Health NHS TrustObekräftadLondon, England
- University College London Hospitals NHS Foundation TrustObekräftadLondon, England
- Sheffield Children's NHS Foundation TrustObekräftadSheffield, England
Vanliga frågor
Will my child definitely get the standard treatment for Kawasaki disease?
Yes. Every child in the trial receives the full, recommended standard treatment (IVIG and aspirin). No child is denied standard care.
Vad är ett ekokardiogram?
An echocardiogram is a heart ultrasound. It uses sound waves to create live pictures of your child's heart and blood vessels. It is completely painless and safe.
How is it decided which group my child goes into?
A computer programme assigns your child to a group at random, like flipping a coin. Neither you nor the doctor can choose the group, ensuring the study results are fair and reliable.
What happens if my child does not get better quickly?
Doctors will closely monitor your child's fever and blood tests. If the swelling does not settle within a few days, your child will receive extra treatments immediately, whichever group they are in.
Can we change our minds after joining?
Yes. You can withdraw your child from the trial at any time. Your decision will not change the quality or type of care your child receives from their medical team.
Hur du får reda på mer
Molly Pursell
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.